Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 304

Quality of Life, Coping, and Social Support in Patients with Multiple Sclerosis: A Pilot Study

Oğuzhan Zengin, Ercüment Erbay, Buğra Yıldırım, Özgür Altındağ

DOI: 10.4274/tnd.37074

Issue: 2017, Volume 23 - Issue 4
0 373

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Vuslat Yılmaz, Deniz Ak Tura, Canan Ulusoy, Duygu Özkan Yaşargün, Suzan Adın Çınar, Recai Türkoğlu

DOI: 10.4274/tnd.87523

Issue: 2017, Volume 23 - Issue 4
0 259

Acute Spinal Pseudoathetosis

Mehmet Fevzi Öztekin, Dilara Mermi Dibek

DOI: 10.4274/tnd.27167

Issue: 2017, Volume 23 - Issue 4
0 209

Weight Loss and Fingolimod

Nefati Kıylıoğlu

DOI: 10.4274/tnd.87528

Issue: 2017, Volume 23 - Issue 4
0 199

Ischemic Stroke Subtypes and Migraine with Visual Aura

Çağla Akı

DOI: 10.4274/tnd.98623

Issue: 2017, Volume 23 - Issue 4
0 247

Serum Lipid Profiles, Relationship Between Paraoxonase/Arylesterase Activity and High-density Lipoprotein Levels in Patients with Migraine

Yasemin Eren, Ebru Bilge Dirik, Salim Neşelioğlu, Özcan Erel

DOI: 10.4274/tnd.09216

Issue: 2017, Volume 23 - Issue 3
0 254

The Effect of Ocrelizumab in the Treatment of Multipl Sclerosis

Şenay Yıldız Çelik

DOI: 10.4274/tnd.71354

Issue: 2017, Volume 23 - Issue 3
0 224

Amiselimod: A New Oral Agent in the Treatment of Multiple Sclerosis

Ahmed Serkan Emekli

DOI: 10.4274/tnd.90018

Issue: 2017, Volume 23 - Issue 3
0 192

Clinical and Demographic Features of Pseudotumor Cerebri Syndrome Diagnosed in a University Hospital

Demet Arslan, Adalet Arıkanoğlu, Eşref Akıl

DOI: 10.4274/tnd.09069

Issue: 2017, Volume 23 - Issue 2
0 251

Raeder’s Syndrome “Paratrigeminal Neuralgia” Beyond Headache: A Case Report

Gülnur Tekgöl Uzuner, Yasemin Dinç, Nevzat Uzuner

DOI: 10.4274/tnd.95867

Issue: 2017, Volume 23 - Issue 2
0 257

Prophylactic Treatment for Migraine in Children: Amitriptyline or Topiramate?

Gonca Bektaş

DOI: 10.4274/tnd.09815

Issue: 2017, Volume 23 - Issue 2
0 218

Relationship Between Ischemic Stroke Subtypes and Migraine with Visual Aura

İpek Güngör Doğan

DOI: 10.4274/tnd.67934

Issue: 2017, Volume 23 - Issue 2
0 218

The Predictive Role of NEDA in the Long-Term Course of Multiple Sclerosis

Özgü Kizek

DOI: 10.4274/tnd.65391

Issue: 2017, Volume 23 - Issue 1
0 217

The effect of abobotulinum toxin A in the prophylactic treatment of refractory migraine

Morteza Mazloum Farsi Baf, Afrouz Alipour, Mehran Homam, Mostafa Khorashadizadeh, Maedeh Beheshti Saadat

DOI: 10.4274/tnd.15986

Issue: 2016, Volume 22 - Issue 4
0 261

Intracranial Hypotension Syndrome with Cortical Venous Thrombosis: A Rare Case

Deepak Jain, Ashima Mittal

DOI: 10.4274/tnd.65471

Issue: 2016, Volume 22 - Issue 4
0 246

Does Serum Vitamin D Level During Pregnancy Influence the Risk of Multiple Sclerosis?

Tuncay Gündüz

DOI: 10.4274/tnd.28566

Issue: 2016, Volume 22 - Issue 4
0 231

Relapses in Multiple Sclerosis: Definition, Pathophysiology, Features, Imitators, and Treatment

Serhan Sevim

DOI: 10.4274/tnd.75318

Issue: 2016, Volume 22 - Issue 3
0 309

Cognitive Impairment in Young Multiple Sclerosis and Essential Tremor Patients: A Comparative Study

Hakan Serdar Şengül, Yıldızhan Şengül, Selma Yücel, Hulki Forta

DOI: 10.4274/tnd.46704

Issue: 2016, Volume 22 - Issue 3
0 303

The Relationship Between Migraine and Nutrition

Ayçıl Özturan, Nevin Şanlıer, Özlem Coşkun

DOI: 10.4274/tnd.37132

Issue: 2016, Volume 22 - Issue 2
0 355